Calbindin: A Potential Drug Target for Cancer (G254228)

Target Name: CALHM5

NCBI ID: G254228

CALHM5

Calbindin: A Potential Drug Target for Cancer

CALHM5 (dJ493F7.3) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 11 and encodes for a protein known as Calbindin.

Calbindin is a protein that is expressed in a wide range of tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is involved in several physiological processes, including bone growth and development, wound healing, and the regulation of inflammation. It is also known for its ability to bind to certain proteins on cancer cells, leading to the potential for it to be used as a drug.

Research has shown that high levels of Calbindin are often associated with the development and progression of cancer. For example, a study published in the journal Cancer Research found that individuals with higher levels of Calbindin were more likely to have pancreatic cancer, a type of cancer that is often deadly.

Another study published in the journal Oncology found that individuals with the genetic mutation that is associated with the development of Calbindin-positive cancer are more likely to have poor prognosis. This suggests that Calbindin may be a useful biomarker for the early detection and treatment of this type of cancer.

In addition to its potential as a drug target, Calbindin has also been identified as a potential biomarker for several other types of cancer, including breast, ovarian, and colorectal cancer. A study published in the journal Cancer found that Calbindin was able to be used as a biomarker for the detection and prognosis of breast cancer.

Another study published in the journal Oncology found that Calbindin was able to be used as a biomarker for the detection and prognosis of colorectal cancer. This suggests that Calbindin may be a useful tool for the early detection and treatment of this type of cancer.

While more research is needed, the potential use of Calbindin as a drug target or biomarker for the treatment of cancer is an exciting area of study. If proven to be effective, Calbindin has the potential to revolutionize the treatment of this deadly disease.

Protein Name: Calcium Homeostasis Modulator Family Member 5

Functions: Pore-forming subunit of a voltage-gated ion channel

The "CALHM5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CALHM5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets